![Alan Musso](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Musso
Director of Finance/CFO at
FULCRUM THERAPEUTICS, INC.
Net worth: 381 000 $ as of 2026-08-30
Profile
Alan A. Musso currently serves as Independent Director at Rein Therapeutics, Inc. since 2023, Independent Director at Research Alliance Corp.
IV starting in 2026, and Treasurer, Chief Financial & Accounting Officer at Fulcrum Therapeutics, Inc. beginning in 2023.
Former positions include Director at Lung Therapeutics LLC from 2022 to 2023; Chief Financial & Accounting Officer at OS Therapies, Inc. in 2023; Chief Financial Officer at ReViral Ltd. from 2019 to 2022; Chief Financial Officer at Peloton Therapeutics, Inc. from 2018 to 2019; Chief Financial Officer & Treasurer at Bellicum Pharmaceuticals, Inc. from 2014 to 2018; CFO, Treasurer, SVP-Finance & Administration at Targacept, Inc. from 2010 to 2014; Chief Financial Officer at Cato Research LLC; Chief Financial Officer at Vascular Genetics, Inc.; Chief Financial Officer & Vice President at Osiris Therapeutics, Inc.; General Accounting Manager-Barceloneta Region at Pfizer Inc.; Chief Financial Officer & Treasurer at Teva Women's Health, Inc. Education includes a graduate degree from Thunderbird School of Global Management conferred in 2008 and an undergraduate degree from St. Mary's College of California conferred in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
2.27% | 2026-07-12 | 30,000 ( 2.27% ) | 381 000 $ | 2026-08-30 |
| 2026-03-30 | 0 ( -.--% ) | - $ | 2026-08-30 | |
| 2026-05-12 | 0 ( -.--% ) | - $ | 2026-08-30 |
Alan Musso active positions
| Companies | Position | Start |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Director of Finance/CFO | 2023-08-06 |
| REIN THERAPEUTICS INC. | Director/Board Member | 2023-10-30 |
Former positions of Alan Musso
| Companies | Position | End |
|---|---|---|
Lung Therapeutics LLC
 Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Director/Board Member | 2023-10-30 |
| OS THERAPIES INCORPORATED | Director of Finance/CFO | 2023-06-29 |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Director of Finance/CFO | 2022-08-31 |
| PELOTON THERAPEUTICS, INC. | Director of Finance/CFO | 2019-08-31 |
| BELLICUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-08-30 |
Training of Alan Musso
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Teva Women's Health, Inc.
 Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Provides women's healthcare products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Thunderbird School of Global Management
 Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
Lung Therapeutics LLC
Lung Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel pipeline of first-in-class medicines for fibrosis | Health Technology |
Vascular Genetics, Inc.
 Vascular Genetics, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical products used in gene therapy | Health Technology |
Cato Research LLC
 Cato Research LLC Miscellaneous Commercial ServicesCommercial Services Specializes in drug development support services for clients in the pharmaceutical, biotechnology and medical device industries | Commercial Services |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
St. Mary's College of California
 St. Mary's College of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReViral Ltd.
ReViral Ltd. BiotechnologyHealth Technology Develops novel antiviral therapeutics | Health Technology |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
OS Therapies, Inc.
 OS Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical stage therapeutic company engages in development and commercialization of treatments for osteosarcoma | Health Technology |
- Stock Market
- Insiders
- Alan Musso
